https://www.avient.com/sites/default/files/2021-01/virtual-reality-application-bulletin.pdf
A LOOK INTO THE FUTURE
VIRTUAL REALITY
APPLICATION BULLETIN
AESTHETIC APPEAL
Metallic and Custom Effects,
FDA-Approved Masterbatch Colorants
SOLUTION: Custom Polymer Colorants,
Pre-Colored Resins
WEARABLE COMFORT
Flexibility, Skin- Compatible Comfort,
Soft Touch, Heat Reduction
SOLUTION: Thermoplastic Elastomers
(TPEs), Thermoplastic Urethanes (TPUs),
Silicone, Nylon (PA)
FUNCTIONALITY
Impact Resistance,
Dimensional Stability, Strength
SOLUTION: Copolyester, PC/
Polyester Blends, Polycarbonate,
Styrenics
BETTER EXPERIENCES.
https://www.avient.com/sites/default/files/2021-01/avient-finland-oy-trade-register-extract-eng-dec-1-2020.pdf
+358 (0)29 509 5000
registry@prh.fi
Page: 1 (2)
Business ID: 2046676-4
Date and time of creating the document: 01.12.2020
08:37:55
TRANSLATION OF THE EXTRACT FROM THE TRADE REGISTER,
ELECTRONIC
01.12.2020 08:37:54 the details in the register
Identifiers
Name Avient Finland Oy
Business ID 2046676-4
Entered in the register 31.03.2007
Company type Limited company
Contact details:
Postal address Äyritie 8 E 01510 Vantaa
Street address Äyritie 8 E 01510 Vantaa
Email tina.ahlquist@clariant.com
Telephone 0106808500
Fax 0106808509
Name details
Name Avient Finland Oy
Auxiliary company name Drycolor
Registered office Vantaa
Share capital
Share capital 169.000,00 €
Number of shares 1 000 pcs
Nominal value of a share 169,00 €
Financial period
Financial period 01.01 - 31.12
Financial statements
The last financial statements submitted 01.01.2019 - 31.12.2019
Representation
Page: 2 (2)
Business ID: 2046676-4
Statutory representation:
Under the law, the Board of Directors represents the company.
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Get Help Now
+1-866-737-2066
Back
Home //
Products //
Polymer Additives //
Healthcare Additives //
Mevopur™ Healthcare Functional Additives
ISO 10993-1, USP and (class VI), USP , European Pharmacopeia monographs 3.1.3 and 3.1.5, ICH Q3D evaluations reduce risk of non-compliance during regulatory submission
https://www.avient.com/products/advanced-composites/continuous-fiber-composite-tape-laminates-and-barstock/polystrand-continuous-fiber-tapes-laminates
Get Help Now
+1-866-737-2066
Back
Home //
Products //
Advanced Composites //
Continuous Fiber Composite Tape, Laminates and Barstock //
Polystrand™ Continuous Fiber Tapes & Laminates
1
https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - English.pdf
The local Avient entity of the jurisdiction for which you are applying for a position will act as a data
controller with respect to your personal information.
1.
You also are entitled to withdraw any
consent that you might have given with respect to the processing of your personal information at any time
with future effect.
Effective Date: August 1, 2020
mailto:PRIVACY.OFFICER@POLYONE.COM
https://privacyportal.onetrust.com/webform/b25cf7b1-a93a-4d26-8c84-ceda4d0ae91b/e180cbe4-d1b9-49bd-b621-cb5f6a0f42cb
mailto:PRIVACY.OFFICER@POLYONE.COM
https://www.avient.com/investor-center/news/polyone-announces-third-quarter-2017-results
Attachment 1
Special items (1)
1)
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1)
AUTO-INJECTOR
APPLICATION STUDY
M A T E R I A L T E C H N O L O G I E S +
S E R V I C E S F O R N E X T
G E N E R A T I O N D E S I G N S
Avient Corporation 1
Avient Corporation 2
Innovating Design
Medical innovations and plastics have gone
hand-in-hand to make healthcare safer, cleaner,
and more accessible for all.
We can help tackle your toughest
challenges with our
• In-depth industry knowledge
• Expansive material solutions
• Far-reaching technical capabilities
and services
Avient Corporation 4
1
Injection window
Integrated rigid
needle shield
2
Cap
3
1.
Requirements:
USP Class VI skin contact
colorant for drug differentiation
Solution:
OnColor™ HC, MEVOPUR® 4
Button
5
Batch or SKU
identifier
Safety and
trigger cap
6
DRUG
CONCENTRATION 1
DRUG
CONCENTRATION 2
DRUG
CONCENTRATION 3
Patient Handling
Age or certain disease states can
severely limit patient dexterity making
the self-administration of
medication difficult and frustrating.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Arab Emirates.pdf
وتابعیھا ("البائع") تسري ھذه الشروط واألحكام على بیع آفینت كوربوریشن
للمنتجات إلى ("مشتري") آخر
1.
If a present or future law, governmental
decree, order, regulation, or ruling under any existing or future legislation
prevents Seller from increasing or revising the price as provided herein, or
nullifies or reduces any price or price increase hereunder, upon written
notice from one to the other, Seller and Buyer will attempt to identify
mutually agreeable changes to conform this contract with such law, decree,
order, regulation, or ruling.
Terms and Conditions (1 April 2024) 2024أبریل 1(الشروط واألحكام(
https://www.avient.com/sites/default/files/2024-05/4b - Governance and Corporate Responsibility Committee Charter.Feb_. 2024.v1.1.Final_.pdf
https://www.avient.com/sites/default/files/2020-09/case-study-one-pager-gls-om-bergamid-victorinox-pen-knife-1.pdf